Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Giustini

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Oncology|January 1, 1984
Morphological damage induced in vivo by Lonidamine on human metastatic cancer cellsC De Martino, T Battelli, R Cavaliere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximabM Scartozzi, R Giampieri, E Maccaroni, et al.
British Journal of Cancer|September 1, 1996
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancerA Piga, S Cascinu, L Latini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based studyC Braconi, R Bracci, I Bearzi, et al.
British Journal of Cancer|March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapyV Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer|August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapyF Graziano, A Ruzzo, F Loupakis, et al.
Lancet (London, England)|April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapyR Passalacqua, F Campione, C Caminiti, et al.
The Pharmacogenomics Journal|December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancerF Graziano, A Ruzzo, E Canestrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancerV Catalano, F Loupakis, F Graziano, et al.
The Pharmacogenomics Journal|June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapyA Ruzzo, F Graziano, F Loupakis, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Oncology|January 1, 1984
Morphological damage induced in vivo by Lonidamine on human metastatic cancer cellsC De Martino, T Battelli, R Cavaliere, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2011
Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximabM Scartozzi, R Giampieri, E Maccaroni, et al.
British Journal of Cancer|September 1, 1996
A phase II randomised trial of 5-fluorouracil with or without interferon alpha-2a in advanced colorectal cancerA Piga, S Cascinu, L Latini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 12, 2008
KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based studyC Braconi, R Bracci, I Bearzi, et al.
British Journal of Cancer|March 5, 2009
Mucinous histology predicts for poor response rate and overall survival of patients with colorectal cancer and treated with first-line oxaliplatin- and/or irinotecan-based chemotherapyV Catalano, F Loupakis, F Graziano, et al.
British Journal of Cancer|August 30, 2008
Liver-only metastatic colorectal cancer patients and thymidylate synthase polymorphisms for predicting response to 5-fluorouracil-based chemotherapyF Graziano, A Ruzzo, F Loupakis, et al.
Lancet (London, England)|April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapyR Passalacqua, F Campione, C Caminiti, et al.
The Pharmacogenomics Journal|December 24, 2008
Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancerF Graziano, A Ruzzo, E Canestrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2011
Prognosis of mucinous histology for patients with radically resected stage II and III colon cancerV Catalano, F Loupakis, F Graziano, et al.
The Pharmacogenomics Journal|June 6, 2007
Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFIRI chemotherapyA Ruzzo, F Graziano, F Loupakis, et al.
Pageof 2